
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7777285
[patent_doc_number] => 20120040385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'COAGULOGEN RAW MATERIAL, PROCESS FOR PRODUCING THE SAME, AND METHOD AND APPARATUS FOR MEASURING PHYSIOLOGICALLY ACTIVE SUBSTANCE OF BIOLOGICAL ORIGIN USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/202285
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11076
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040385.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202285
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202285 | Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same | Feb 18, 2010 | Issued |
Array
(
[id] => 7581105
[patent_doc_number] => 20110294988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Purification Process'
[patent_app_type] => utility
[patent_app_number] => 13/148260
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16054
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294988.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148260
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148260 | Purification Process | Feb 4, 2010 | Abandoned |
Array
(
[id] => 8199297
[patent_doc_number] => 20120122791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'SUBSTRATE FOR CARTILAGE CULTIVATION USING ARTIFICIAL COLLAGEN, AND METHOD FOR CARTILAGE REGENERATION TREATMENT USING THE SUBSTRATE'
[patent_app_type] => utility
[patent_app_number] => 13/318312
[patent_app_country] => US
[patent_app_date] => 2010-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10858
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122791.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318312 | SUBSTRATE FOR CARTILAGE CULTIVATION USING ARTIFICIAL COLLAGEN, AND METHOD FOR CARTILAGE REGENERATION TREATMENT USING THE SUBSTRATE | Feb 1, 2010 | Abandoned |
Array
(
[id] => 10547392
[patent_doc_number] => 09271992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds'
[patent_app_type] => utility
[patent_app_number] => 12/696250
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 173
[patent_figures_cnt] => 54
[patent_no_of_words] => 16598
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12696250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/696250 | Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds | Jan 28, 2010 | Issued |
Array
(
[id] => 6510468
[patent_doc_number] => 20100210745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes'
[patent_app_type] => utility
[patent_app_number] => 12/696651
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 343081
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210745.pdf
[firstpage_image] =>[orig_patent_app_number] => 12696651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/696651 | Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes | Jan 28, 2010 | Abandoned |
Array
(
[id] => 7587522
[patent_doc_number] => 20110282032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'PROCESS FOR HIGHLY SELECTIVE PURIFICATION OF TWO PLASMA PROTEINS: VON WILLEBRAND FACTOR (VWF) AND FIBRONECTIN (FN)'
[patent_app_type] => utility
[patent_app_number] => 13/145038
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2923
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20110282032.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145038 | Process for highly selective purification of two plasma proteins: von willebrand factor (vWF) and fibronectin (Fn) | Jan 18, 2010 | Issued |
Array
(
[id] => 7567005
[patent_doc_number] => 20110287068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'FIBRIN AND FIBRINOGEN MATRICES AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 13/143196
[patent_app_country] => US
[patent_app_date] => 2009-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15871
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287068.pdf
[firstpage_image] =>[orig_patent_app_number] => 13143196
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143196 | FIBRIN AND FIBRINOGEN MATRICES AND USES OF SAME | Dec 30, 2009 | Abandoned |
Array
(
[id] => 7695945
[patent_doc_number] => 20110230645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'PURIFICATION OF FACTOR V'
[patent_app_type] => utility
[patent_app_number] => 13/131001
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6420
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230645.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131001
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131001 | PURIFICATION OF FACTOR V | Dec 14, 2009 | Abandoned |
Array
(
[id] => 6431208
[patent_doc_number] => 20100152115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'DETECTION OF PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULES USING NEAR INFRARED SPECTROSCOPY'
[patent_app_type] => utility
[patent_app_number] => 12/636382
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9344
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152115.pdf
[firstpage_image] =>[orig_patent_app_number] => 12636382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/636382 | DETECTION OF PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULES USING NEAR INFRARED SPECTROSCOPY | Dec 10, 2009 | Abandoned |
Array
(
[id] => 6413540
[patent_doc_number] => 20100166834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'PREPARATIONS BASED ON FIBRINOGEN AND SULFATED POLYSACCHARIDES'
[patent_app_type] => utility
[patent_app_number] => 12/636620
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9281
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12636620
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/636620 | Preparations based on fibrinogen and sulfated polysaccharides | Dec 10, 2009 | Issued |
Array
(
[id] => 7567455
[patent_doc_number] => 20110287518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'Polypeptide Purification'
[patent_app_type] => utility
[patent_app_number] => 13/131757
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12887
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287518.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131757
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131757 | Polypeptide Purification | Nov 30, 2009 | Abandoned |
Array
(
[id] => 5929821
[patent_doc_number] => 20110039780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'PLATELET GLYCOPROTEIN IB ALPHA VARIANT FUSION POLYPEPTIDES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/621887
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10384
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039780.pdf
[firstpage_image] =>[orig_patent_app_number] => 12621887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/621887 | PLATELET GLYCOPROTEIN IB ALPHA VARIANT FUSION POLYPEPTIDES AND METHODS OF USE THEREOF | Nov 18, 2009 | Abandoned |
Array
(
[id] => 11197304
[patent_doc_number] => 09427499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials'
[patent_app_type] => utility
[patent_app_number] => 13/129738
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 11190
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129738
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129738 | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials | Nov 16, 2009 | Issued |
Array
(
[id] => 5976825
[patent_doc_number] => 20110070625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'NOVEL FLUORESCENT PROTEINS AND METHODS FOR USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/619488
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14836
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070625.pdf
[firstpage_image] =>[orig_patent_app_number] => 12619488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/619488 | Fluorescent proteins and methods for using same | Nov 15, 2009 | Issued |
Array
(
[id] => 6543115
[patent_doc_number] => 20100125052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-20
[patent_title] => 'ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/616735
[patent_app_country] => US
[patent_app_date] => 2009-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 34174
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20100125052.pdf
[firstpage_image] =>[orig_patent_app_number] => 12616735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/616735 | Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents | Nov 10, 2009 | Issued |
Array
(
[id] => 6423820
[patent_doc_number] => 20100168018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'FACTOR VIII FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/614090
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16589
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12614090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/614090 | FACTOR VIII FORMULATIONS | Nov 5, 2009 | Abandoned |
Array
(
[id] => 7686048
[patent_doc_number] => 20100120093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Method of Producing Serum-Free Insulin-Free Factor VII'
[patent_app_type] => utility
[patent_app_number] => 12/612752
[patent_app_country] => US
[patent_app_date] => 2009-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14157
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12612752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/612752 | Method of Producing Serum-Free Insulin-Free Factor VII | Nov 4, 2009 | Abandoned |
Array
(
[id] => 6322950
[patent_doc_number] => 20100113743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA'
[patent_app_type] => utility
[patent_app_number] => 12/605041
[patent_app_country] => US
[patent_app_date] => 2009-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 44429
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12605041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/605041 | GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA | Oct 22, 2009 | Abandoned |
Array
(
[id] => 7743305
[patent_doc_number] => 20120021484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Recombinant FcRn and Variants Thereof for Purification of Fc-Containing Fusion Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/125795
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13338
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021484.pdf
[firstpage_image] =>[orig_patent_app_number] => 13125795
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125795 | Recombinant FcRn and Variants Thereof for Purification of Fc-Containing Fusion Proteins | Oct 20, 2009 | Abandoned |
Array
(
[id] => 6250379
[patent_doc_number] => 20100137816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Injection of fibrin sealant including an anesthetic in spinal applications'
[patent_app_type] => utility
[patent_app_number] => 12/587309
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5887
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137816.pdf
[firstpage_image] =>[orig_patent_app_number] => 12587309
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/587309 | Injection of fibrin sealant including an anesthetic in spinal applications | Oct 4, 2009 | Issued |